Clinical trial Recruiting at 2 sites Observational Ages 18 and up

MMVD: A Multicenter Registry to Understand Multiple and Mixed Valvular Heart Disease

Official title: MULTIVALVE : A Prospective Multicentre Study of Multiple and Mixed Valvular Heart Disease

Run by French Cardiology Society · NCT07176507 · Data updated 2026-11-12

This study tests how common MMVD is, what imaging and management practices are used, and what factors influence outcomes in adults with two or more valve issues.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1000 (estimated)
SponsorFrench Cardiology Society
Academic / other
Locations2 sites (Lille and 1 other locations)
StatusRecruiting
StartedOctober 30, 2025
Main results expectedOctober 2028
Study endsOctober 2032
Registry record updatedJune 12, 2026
Trial IDNCT07176507 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with echocardiographically confirmed MMVD (two or more moderate-to-severe valvulopathies) who have not had valve surgery or intervention.

Probably not a fit

Patients without MMVD or those with prior valve surgery or current acute endocarditis may not benefit from this observational registry.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This national, prospective registry collects data from adults diagnosed with MMVD across multiple centers. Participants are followed at 1, 2, 3, 4, and 5 years to document clinical status, imaging results, and treatment approaches. The study aims to describe prevalence, imaging strategies, and management patterns, and to identify prognostic factors for different combinations of valve disease. It does not assign a specific intervention but observes real-world care to improve guidance beyond isolated valve disease recommendations. Enrollment requires echocardiographic confirmation of MMVD and informed consent.

Why it matters

Potential benefit: If successful, the registry could clarify best practices and improve guidelines for managing patients with complex valve disease.

How similar studies have gone: Previous registries in valvular disease have helped describe practice patterns and prognostic factors, but MMVD-specific multicenter data are limited and this study addresses that gap.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years
* The patient has been informed of the study and has not refused to participate.
* An echocardiographic diagnosis of MMVD is defined as having at least two moderate to severe valvulopathies, as assessed by a cardiologist using transthoracic echocardiography (TTE), on one or more valves. This is in line with the recommendations of the ESC, the ASE, and expert opinion.

Exclusion Criteria:

* History of valve surgery or percutaneous valve intervention involving the valve in question.
* A history of infective endocarditis, whether treated surgically or not, confirmed according to the modified Duke criteria.
* Acute infective endocarditis at the time of evaluation for inclusion, confirmed according to the modified Duke criteria.
* Complex congenital heart disease.
* Patients who are already included in the European EACVI-MMVD study.
* Pregnant women
* Patients not affiliated to social security
* Patients who are minors
* Patients under guardianship, curatorship or judicial supervision
* Patients who refuse to participate in this register.

Where it's running

  • Chu Lille- Hopital Cardiologique
    Lille, France
    Recruiting
  • Chu Lariboisiere (Aphp)
    Paris, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.